These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20737150)

  • 1. Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry.
    Sardi I; la Marca G; Giovannini MG; Malvagia S; Guerrini R; Genitori L; Massimino M; Aricò M
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1333-40. PubMed ID: 20737150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivo.
    Sardi I; Fantappiè O; la Marca G; Giovannini MG; Iorio AL; da Ros M; Malvagia S; Cardellicchio S; Giunti L; de Martino M; Mazzanti R
    Cancer Lett; 2014 Oct; 353(2):242-7. PubMed ID: 25079687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M
    Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in blood-brain barrier function and brain pathology by morphine in the rat. Neuroprotective effects of antioxidant H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Acta Neurochir Suppl; 2010; 106():61-6. PubMed ID: 19812922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of narcotics on the uptake of serotonin precursors by the rat brain.
    Larson AA; Takemori AE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):216-23. PubMed ID: 299890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion rates and drug distribution in brain tumor models in rats.
    Khan A; Jallo GI; Liu YJ; Carson BS; Guarnieri M
    J Neurosurg; 2005 Jan; 102(1 Suppl):53-8. PubMed ID: 16206734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain.
    Sardi I; la Marca G; Cardellicchio S; Giunti L; Malvagia S; Genitori L; Massimino M; de Martino M; Giovannini MG
    Am J Cancer Res; 2013; 3(4):424-32. PubMed ID: 23977451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine enhances doxorubicin-induced cardiotoxicity in the rat.
    Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J
    Cardiovasc Toxicol; 2014 Sep; 14(3):251-9. PubMed ID: 24531975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triolein Emulsion Infusion Into the Carotid Artery Increases Brain Permeability to Anticancer Agents.
    Kim HJ; Kim YW; Choi SH; Cho BM; Bandu R; Ahn HS; Kim KP
    Neurosurgery; 2016 May; 78(5):726-33. PubMed ID: 26540353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered brain exposure of morphine in experimental meningitis studied with microdialysis.
    Tunblad K; Ederoth P; Gärdenfors A; Hammarlund-Udenaes M; Nordström CH
    Acta Anaesthesiol Scand; 2004 Mar; 48(3):294-301. PubMed ID: 14982561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of aluminum exposure associated with lipid peroxidation in rat brain.
    Ogasawara Y; Ohata E; Sakamoto T; Ishii K; Takahashi H; Tanabe S
    Biol Trace Elem Res; 2003; 96(1-3):191-201. PubMed ID: 14716098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats.
    Sharma HS; Lundstedt T; Boman A; Lek P; Seifert E; Wiklund L; Ali SF
    Ann N Y Acad Sci; 2006 Aug; 1074():482-96. PubMed ID: 17105947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
    Bahcekapili N; Uzüm G; Gökkusu C; Kuru A; Ziylan YZ
    Life Sci; 2007 Mar; 80(14):1245-51. PubMed ID: 17300815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats.
    Mostafa AM; Nagi MN; Al Rikabi AC; Al-Shabanah OA; El-Kashef HA
    Res Commun Mol Pathol Pharmacol; 1999; 106(3):193-202. PubMed ID: 11485049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
    Nye HE; Nestler EJ
    Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo NMR study of lactate metabolism in rat brain under various depressed states.
    Serres S; Bezancon E; Franconi JM; Merle M
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):19-25. PubMed ID: 15558748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3Alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator.
    Mikov M; Kevresan S; Kuhajda K; Jakovljević V; Vasović V
    Pol J Pharmacol; 2004; 56(3):367-71. PubMed ID: 15215568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.
    Kuschinsky K
    Arzneimittelforschung; 1976 Apr; 26(4):563-7. PubMed ID: 8059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.